Arkolith/Insider Trading/STRO/Form 4

Hallam Trevor

Chief Scientific OfficerSUTRO BIOPHARMA, INC. (STRO) · full profile →Form 4 · filed Jan 27, 2021
Net Selling
Open-Market Buys
$0
Open-Market Sells
$62K
Net Open-Market Flow
-$62K
Transactions
4
3 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 26, 2021Sell(S)165$26.10$4K56K
Jan 26, 2021Sell(S)2K$25.68$57K56K
Jan 26, 2021Option exercise(M)2K$4.36$10K59K

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 26, 2021Option exercise(M)2K—$04

Transaction Codes

S
Open-market sale
M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001209191-21-005712) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML

Keep exploring

Connected pages for SUTRO BIOPHARMA, INC.

Build

Build on these Form 4 transactions

The public view is the crawlable proof. The same sourced dataset is available through REST and MCP for agents, research scripts, and back-office tools.

Form 4 insider API

Open-market buys and sells, cluster scans, company flows.

insider.transactions

13F holdings API

Owners, holdings, deltas, point-in-time portfolios.

stock.owners

MCP quickstart

Connect an agent, mint a key, make the first call.

/api/mcp